230 related articles for article (PubMed ID: 28932159)
1. The use of performance-enhancing substances (doping) by athletes in Saudi Arabia.
Al Ghobain M
J Family Community Med; 2017; 24(3):151-155. PubMed ID: 28932159
[TBL] [Abstract][Full Text] [Related]
2. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
Negro F; Di Trana A; Marinelli S
Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
[TBL] [Abstract][Full Text] [Related]
3. A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.
Kioukia-Fougia N; Fragkaki A; Kiousi P; Leontiou IP; Dimopoulou H; Tsivou M; Lyris E; Georgakopoulos C
J Anal Toxicol; 2014; 38(1):16-23. PubMed ID: 24194481
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
[TBL] [Abstract][Full Text] [Related]
5. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
6. Investigating the use of stimulants in out-of-competition sport samples.
Boghosian T; Mazzoni I; Barroso O; Rabin O
J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
[TBL] [Abstract][Full Text] [Related]
7. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution.
Oleksak P; Nepovimova E; Valko M; Alwasel S; Alomar S; Kuca K
Environ Toxicol Pharmacol; 2024 Jun; 108():104447. PubMed ID: 38636744
[TBL] [Abstract][Full Text] [Related]
9. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration.
Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A
Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604
[TBL] [Abstract][Full Text] [Related]
11. Doping control from a global and national perspective.
Fraser AD
Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
[TBL] [Abstract][Full Text] [Related]
12. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
Mercado Soberanes K; Camacho Frías E; Rodríguez Balandrán L; Rodríguez Fermán ME; Mendoza Méndez N; Velasco-Bejarano B
Adicciones; 2019 Jul; 31(3):201-211. PubMed ID: 30059594
[TBL] [Abstract][Full Text] [Related]
13. [Medication, athletes and doping regulations].
Hartgens F
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
[TBL] [Abstract][Full Text] [Related]
14. Meldonium use by athletes at the Baku 2015 European Games.
Stuart M; Schneider C; Steinbach K
Br J Sports Med; 2016 Jun; 50(11):694-8. PubMed ID: 27015859
[TBL] [Abstract][Full Text] [Related]
15. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples.
Walpurgis K; Scheiff AB; Welz M; Müller-Reul J; Webborn N; Görgens C; Guddat S; Fußhöller G; Dib J; Thevis M
Drug Test Anal; 2019 Nov; 11(11-12):1755-1760. PubMed ID: 31670462
[TBL] [Abstract][Full Text] [Related]
16. Thirteen years of the fight against doping in figures.
Aguilar M; Muñoz-Guerra J; Plata MDM; Del Coso J
Drug Test Anal; 2017 Jun; 9(6):866-869. PubMed ID: 28105782
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Bieri A; Kamber M; Sterchi M; Mullis PE
Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
[TBL] [Abstract][Full Text] [Related]
18. Possibility of analytical finding of glycerol caused by self-catheterization in doping control.
Okano M; Nishitani Y; Kageyama S
Drug Test Anal; 2014; 6(11-12):1151-4. PubMed ID: 25079056
[TBL] [Abstract][Full Text] [Related]
19. Structure and Development of the List of Prohibited Substances and Methods.
Kinahan A; Budgett R; Mazzoni I
Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
[TBL] [Abstract][Full Text] [Related]
20. Intended or Unintended Doping? A Review of the Presence of Doping Substances in Dietary Supplements Used in Sports.
Martínez-Sanz JM; Sospedra I; Ortiz CM; Baladía E; Gil-Izquierdo A; Ortiz-Moncada R
Nutrients; 2017 Oct; 9(10):. PubMed ID: 28976928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
